Biotron Limited logo

Biotron Limited

ASX:BIT.AX

Overview | Financials
Company Name Biotron Limited
Symbol BIT.AX
Currency AUD
Price 0.045
Market Cap 44,133,042
Dividend Yield 0%
52-week-range 0.024 - 0.125
Industry Biotechnology
Sector Healthcare
CEO Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.
Website https://www.biotron.com.au

An error occurred while fetching data.

About Biotron Limited

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in

Related Stocks

Micro-X Limited logo

Micro-X Limited

MX1.AX

0.086 AUD

Invion Limited logo

Invion Limited

IVX.AX

0.004 AUD

Doctor Care Anywhere Group PLC logo

Doctor Care Anywhere Group PLC

DOC.AX

0.065 AUD

CleanSpace Holdings Limited logo

CleanSpace Holdings Limited

CSX.AX

0.28 AUD

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.45 AUD

Emyria Limited logo

Emyria Limited

EMD.AX

0.05 AUD

Botanix Pharmaceuticals Limited logo

Botanix Pharmaceuticals Limited

BOT.AX

0.31 AUD

Orthocell Limited logo

Orthocell Limited

OCC.AX

0.375 AUD

Microba Life Sciences Limited logo

Microba Life Sciences Limited

MAP.AX

0.175 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD